focus -WSS

focus

author：Wikipedia 2025-09-30 00:34:25 - browse：197

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly — ruling that the treatment’s ability to slow the cognitive decline in patients outweighed its safety risks.

The unanimous outcome of the daylong advisory panel was the best-case scenario for Lilly, making it likely that the FDA will approve the drug, called donanemab, for a broad population of people diagnosed with mild cognitive impairment due to Alzheimer’s. A decision is expected later this year.

“The benefits outweigh the risks, as long as the risks are being monitored,” said Kathleen Poston, a neurologist at Stanford University and a member of the advisory panel.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Diagnostic tests are hitting their mathematical limits

focus

WSS

Mayo Clinic plans $5B tech

Bispecific antibodies are next new thing in cancer immunotherapy

Millions may soon lose Medicaid when they don't have to

U.K. Biobank has 500,000 peoples' genome sequences available

Biogen nominates mother of director’s child to replace him on board

Mom launches Girl Scout troop for LGBTQ youth in Texas

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Guidelines to prevent youth baseball injuries need more muscle

What don’t we know about an Alzheimer’s drug side effect?

After affirmative action ruling, medical educators look to 'holistic review'

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Wildfire smoke exposes gaps in outdoor worker protections

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A public health expert passes on football's full body collisions for youths

explore

UnitedHealth’s Optum accused of antitrust violations in California

FDA investigates CAR

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Can medical device makers keep up in the race to treat obesity?

How to fix the rural physician shortage in the U.S.

focus

explore

focus

focus